Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | POET | GFS |
|---|---|---|
| Price | $7.81 | $48.56 |
| Change today | ▲ 0.26% | ▼ 3.21% |
| Market cap | $1.35B | $27.07B |
| Return, 3 months | -5.6% | -26.1% |
| Return, year to date | +23.4% | +39.6% |
| Return, 1 year | +22.4% | +35.7% |
| P/E (TTM) | -11.3 | 37.9 |
| P/B | 1.6 | 2.3 |
| P/E percentile vs own 5y | – | 81st |
| Dividend yield | – | 0.25% |
| Revenue growth (YoY, latest qtr) | – | +5.8% |
| Net profit growth (YoY) | – | -26.8% |
| Gross margin | – | 27.1% |
| Operating margin | – | 11.6% |
| Net margin | – | 10.3% |
| Return on equity | – | 6.1% |
| Analyst target vs. price | – | +52.8% |
| Analyst buy share | – | 50% |
| RSI (14) | 50 | 53 |
| 30-day volatility | 67.5% | 44.5% |
| Max drawdown, 1 year | -69.0% | -52.4% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
